The questions shareholders need to ask management are:
What were your revenue expectations for this Quarterly?
The answer goes to the core of the transparency concern we all have.
OBJ said long ago that you will just see revenue appear. In this report they said to expect a gradual increase so what does this mean for the next 4C - $60K? Do they have any idea?
Does an OBJ auditor just accept a line item total that P&G says the company is owed each quarter?
What happens when they have multiple products? Will OBJ even know which are selling and which are not?
Regarding the new upfront payment, shareholders must question when this will occur. Will it appear in the next 4C and will it be lumped into 'Receipts from Customers'.
- Forums
- ASX - By Stock
- WFL
- To sell or not to sell, that is the question
WFL
wellfully limited
Add to My Watchlist
0.00%
!
0.3¢

To sell or not to sell, that is the question, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
AFP
AFT PHARMACEUTICALS LIMITED
Dr. Hartley Atkinson, MD
Dr. Hartley Atkinson
MD
Previous Video
Next Video
SPONSORED BY The Market Online